唾液NT-proBNP在心脏衰竭中的潜在作用
Aidonis Rammos1, Aris Bechlioulis1, Petros Kalogeras1
12nd Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina & University Hospital of Ioannina, 45110 Ioannina, Greece.
Life (Basel, Switzerland)
|September 28, 2023
概括
唾液NT-proBNP在急性不补偿性心力衰竭 (ADHF) 中与血清NT-proBNP相关,但不能将心力衰竭与其他疾病区分开来. 需要进一步的研究来评估唾液NT-proBNP的诊断效用.
科学领域:
- 生物标志物 生物标志物
- 心脏病学 心脏病学
- 诊断工具 诊断工具
背景情况:
- 血清性尿素 (NP) 是确立的心力衰竭 (HF) 诊断的生物标志物.
- 唾液NT-proBNP提供了一种侵入性较小的替代品,但对其进行的研究很少.
- 研究唾液NT-proBNP可以提供一种更容易获得的诊断方法.
研究的目的:
- 在怀疑心力衰竭的患者中评估唾液NT-proBNP的诊断潜力.
- 为了比较唾液NT-proBNP水平与血清NT-proBNP和临床参数.
- 为了确定唾液NT-proBNP是否能区分心力衰竭和呼吸障碍的其他原因.
主要方法:
- 纳入了99名受试者,包括对照组,慢性心力衰竭 (CHF) 患者和急性无补偿心力衰竭 (ADHF) 患者.
- 收集的数据包括心电图,心声图,6分钟步行距离 (6MWD),以及血液和唾液样本.
- 测量和分析与临床数据相关的血清和唾液NT-proBNP水平.
主要成果:
- 与对照组相比,ADHF和CHF患者的血清NT-proBNP水平显著更高.
- 唾液NT-proBNP水平在ADHF,CHF和对照组之间没有显著差异.
- 唾液和血清NT-proBNP水平仅与ADHF患者相关;唾液NT-proBNP与这个群体的年龄相关.
结论:
- 唾液NT-proBNP与ADHF中的血清NT-proBNP相关,但无法区分HF与其他呼吸障碍原因.
- 这项研究表明,唾液NT-proBNP可能不是可靠的独立生物标志物用于HF诊断.
- 需要进一步的研究来探索唾液NT-proBNP的临床实用性和潜在应用.
相关概念视频
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
110
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
01:30Heart Failure VII: Nursing Interventions
89
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
89
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K